Publication Cover
Global Public Health
An International Journal for Research, Policy and Practice
Volume 14, 2019 - Issue 2
318
Views
8
CrossRef citations to date
0
Altmetric
Articles

Trends and challenges in diabetes for middle-income countries: Evidence from Mexico

, , , , &
Pages 227-240 | Received 23 Nov 2017, Accepted 03 Jul 2018, Published online: 01 Aug 2018

References

  • American Diabetes Association (ADA). (2013). Economic costs of diabetes in the U.S. in 2012. Diabetes Care, 36, 1033–1046. doi: 10.2337/dc12-2625
  • Arredondo, A. (2014). Type 2 diabetes and health care costs in Latin America: Exploring the need for greater preventive medicine. BMC Medicine, 12(136), 11–19.
  • Arredondo, A., Aviles, R., & Azar, A. (2017, January). Costos y consecuencias financieras del cambio en el perfil epidemiológico en México. University of Montreal-INSP. Update of probabilistic models, Final Report, 12-19.
  • Arredondo, A., & Barceló, A. (2007). The economic burden of out-of-pocket medical expenditures for patients seeking diabetes care in Mexico. Diabetologia, 50, 435–436. doi: 10.1007/s00125-007-0828-4
  • Arredondo, A., Cuadra, M., & Duarte, M. (2015). Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: Evidence from mexico. BMC Public Health, 15, 1106–1106. doi: 10.1186/s12889-015-2430-x
  • Barcelo, A., Aedo, C., Rajpathak, S., & Robles, S. (2003). The cost of diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization, 81, 19–27.
  • BM Banco de México. (2016). Indice Nacional de Precios por Servicios Médicos en México. Cuadernos Mensuales, Base 2000=100. La Actividad Económica en México. 1992–2014. Gerencia de Investigación Económica. Banco de México Ed. México DF, México (pp. 67–71).
  • Brown, J. B., Pedula, K. L., & Bakst, A. W. (1999). The progressive cost of complications in type 2 diabetes mellitus. Archives of Internal Medicine, 159, 1873–1880. doi: 10.1001/archinte.159.16.1873
  • Candian Diabetes Asociation. (2009, December). An economic tsunami: The cost of diabetes in Canada. Canadian Diabetes Association. The Prevalence and Costs of Diabetes. Retrieved from www.diabetes.ca/about-diabetes
  • Caspersen, C., Thomas, D., Boseman, L., Beckles, G., & Aging, A. A. (2012). Aging, diabetes, and the public health system in the United States. American Journal of Public Health, 102(8), 1482–1497. doi: 10.2105/AJPH.2011.300616
  • Cercone, J. (2014). Asociación público-privada para la atención a la salud. El desafío de costos en la reforma en salud. Foro de Europa y América sobre las Reformas del Sector Salud. Banco Mundial-IESE, 2, 6–11.
  • CONACYT. Fondo Sectorial Salud. Convocatoria. 2015. Terminos de Referencia para el desarrollo de proyectos de investigación. México DF (pp. 6–14).
  • De Icaza, E., et al. (2016). Estimación de costos y demanda esperada de enfermedades crónico-degenerativas. Informe Técnico. INSP. Cuernavaca, México (pp. 34–46).
  • Gálvez, A. (2007). Salud Basada en la Evidencia. Cómo incorporar la investigación cualitativa a la práctica de los cuidados en salud. Estudios de Sombra. Ed. Fundación Index: Granada (pp. 13–26).
  • International Diabetes Federation. (2012). Direct cost to the health care sector (pp. 13–15). Brussels: Diabetes Health Economics. International Diabetes Federation.
  • International Diabetes Federation. (2017). Direct cost to the health care sector ( pp. 29–35). Brussels: Diabetes Health Economics. International Diabetes Federation.
  • Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., … Murray, C. J. L. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. The Lancet, 380, 2095–2128. doi: 10.1016/S0140-6736(12)61728-0
  • Murray A. (2005). Statistical modelling and statistical inference: Measurement error in the explanatory variables. Box-Jenkins technique, in Statistical Modelling in GLIM. Oxford Science Publications, Ox. Uni. Press, New York, U.S.A.; Third Ed. Chap. 2 (pp. 112–132).
  • National Institute of Public Health. (2017). Métodos de estimación de cambios epidemiológicos y demanda esperada de enfermedades crónico-degenerativas (pp. 12–22). Cuernavaca: Informe Técnico de Memoria Metodológica.
  • Nájera, P. (2006). Who pays more for health services in middle income countries: Lessons from Mexico. Jou of Public Health, 119(8), 39–43.
  • Panamerican Health Organization. (2006). Health analysis and information systems. Regional Mortality Database, 16, 21.
  • Shaw, J., Sicree, R., & Zimment, P. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87(1), 4–14. doi: 10.1016/j.diabres.2009.10.007
  • Snowdon, A., Schnarr, K., Hussein, A., & Alessi, A. (2012). Measuring what matters: The cost vs. Values of health care (pp. 12–20). Ontario, CA: International Centre for Health Innovation, Richard Ivey School of Business, Western University.
  • SSA. (2015a). Encuesta Nacional Salud y Nutrición: Diabetes. Tercera Edición, SSA, México D.F. 2015 (pp. 186–191).
  • SSA. (2015b). Boletín de Información Estadística. Casos de morbilidad hospitalaria por demanda específica, 1996-2013. México, D.F: SSA Ed.
  • SSA. (2016a). Reporte Anual de Casos de Enfermedades Cronicas. Sistema Único de Información para la Vigilancia Epidemiológica. Dirección General de Epidemiología. SSA. Mexico DF. 1996–2015 (pp. 11–12).
  • SSA. (2016b). Tabulador de sueldos de las ramas medica, paramedica y grupos afines. Mexico 2016. Retrieved from dgrh.salud.gob.mx/Servicios/TABULADOR_2017.pdf
  • SSA. (2017). Cuadro Básico y Catálogo de Insumos del sector salud. medicamentos material de curación · auxiliares de diagnóstico, varios. Retrieved from http://www.csg.gob.mx/contenidos/CB/2017/cuadro_basico.html
  • SSA. (2018). Estrategia Nacional para la Prevención y el Control del Sobrepeso, la Obesidad y la Diabetes. Programa de sitesis ejecutiva. México. 2014. Retrieved from http://promocion.salud.gob.mx/dgps/descargas1/estrategia/SIntesis_Ejecutiva.pdf
  • Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047–1053. doi: 10.2337/diacare.27.5.1047
  • Zhang, P., Zhang, X., Brown, J., Vistisen, D., & Sicree, R. (2010). Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research, 87, 293–301.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.